spikevax moderna - Search News

News

Moderna, COVID-19

WGNO on MSN · 1h

Moderna gets full FDA approval for kids COVID-19 vaccine

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory winning streak, which has also included nods for a next-gen COVID-19 vaccine and an RSV shot.

Reuters on MSN · 22h

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

The Pharma Letter4h

FDA grants approval for Spikevax in young children

The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...

Quick takes: WHO arbovirus guidance, H5N1 in US mammals, re-blocking southern border livestock imports

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

1don MSN

Pfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K.

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

6don MSN

Why Moderna Stock Was So Healthy This Week

On Monday, Moderna published the results of a late-stage study of mRNA-1010, its seasonal flu vaccine. In a phase 3 clinical ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results